Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001402BKPyvENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS42000404EBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10004842HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10004841HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10019268HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10005938HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10005939HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10013178HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10013179HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS10005762HBVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TCGA Plot Options
Drug Information
GeneRYR2
DrugBank IDDB09085
Drug NameTetracaine
Target IDBE0005295
UniProt IDQ92736
Regulation Typemodulator
PubMed IDs21624373; 20961976
CitationsLaver DR, van Helden DF: Three independent mechanisms contribute to tetracaine inhibition of cardiac calcium release channels. J Mol Cell Cardiol. 2011 Sep;51(3):357-69. doi: 10.1016/j.yjmcc.2011.05.009. Epub 2011 May 19.@@Lanner JT, Georgiou DK, Joshi AD, Hamilton SL: Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol. 2010 Nov;2(11):a003996. doi: 10.1101/cshperspect.a003996. Epub 2010 Oct 20.
GroupsApproved; Vet_approved
Direct ClassificationBenzoic acid esters
SMILESCCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
Pathways
PharmGKBPA451638
ChEMBLCHEMBL698